vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and YORK WATER CO (YORW). Click either name above to swap in a different company.
YORK WATER CO is the larger business by last-quarter revenue ($19.4M vs $12.6M, roughly 1.5× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 26.7%, a 224.0% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 3.2%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 5.1%).
The York Water Company is an investor-owned, public utility company based in York, Pennsylvania and operating throughout Pennsylvania. The company was founded in 1816 by a group of local businessmen concerned about fire protection.
SPRO vs YORW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $19.4M |
| Net Profit | $31.5M | $5.2M |
| Gross Margin | — | — |
| Operating Margin | — | 33.2% |
| Net Margin | 250.7% | 26.7% |
| Revenue YoY | 24080.8% | 3.2% |
| Net Profit YoY | 250.9% | 0.5% |
| EPS (diluted) | $0.56 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | $19.4M | ||
| Q3 25 | $0 | $20.2M | ||
| Q2 25 | $0 | $19.1M | ||
| Q1 25 | $12.0K | $18.3M | ||
| Q4 24 | $52.0K | $18.8M | ||
| Q3 24 | $65.0K | $19.6M | ||
| Q2 24 | $114.0K | $18.6M | ||
| Q1 24 | $140.0K | $17.5M |
| Q4 25 | $31.5M | $5.2M | ||
| Q3 25 | $-7.4M | $6.2M | ||
| Q2 25 | $-1.7M | $5.1M | ||
| Q1 25 | $-13.9M | $3.6M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $-17.1M | $5.9M | ||
| Q2 24 | $-17.9M | $5.0M | ||
| Q1 24 | $-12.7M | $4.3M |
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 39.1% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | -122758.3% | 34.3% | ||
| Q4 24 | — | 35.8% | ||
| Q3 24 | -28604.6% | 41.1% | ||
| Q2 24 | -16720.2% | 37.9% | ||
| Q1 24 | -9987.1% | 35.5% |
| Q4 25 | 250.7% | 26.7% | ||
| Q3 25 | — | 30.6% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | -115550.0% | 19.8% | ||
| Q4 24 | — | 27.4% | ||
| Q3 24 | -26380.0% | 29.9% | ||
| Q2 24 | -15668.4% | 26.8% | ||
| Q1 24 | -9049.3% | 24.7% |
| Q4 25 | $0.56 | $0.36 | ||
| Q3 25 | $-0.13 | $0.43 | ||
| Q2 25 | $-0.03 | $0.35 | ||
| Q1 25 | $-0.25 | $0.25 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | $-0.32 | $0.41 | ||
| Q2 24 | $-0.33 | $0.35 | ||
| Q1 24 | $-0.24 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | $1.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $59.0M | $240.3M |
| Total Assets | $68.9M | $680.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | $1.0K | ||
| Q3 25 | $48.6M | $1.0K | ||
| Q2 25 | $31.2M | $1.0K | ||
| Q1 25 | $48.9M | $1.0K | ||
| Q4 24 | $52.9M | $1.0K | ||
| Q3 24 | $76.3M | $1.0K | ||
| Q2 24 | $63.5M | $1.0K | ||
| Q1 24 | $82.3M | $3.3M |
| Q4 25 | $59.0M | $240.3M | ||
| Q3 25 | $26.5M | $238.0M | ||
| Q2 25 | $32.8M | $234.6M | ||
| Q1 25 | $33.8M | $232.1M | ||
| Q4 24 | $46.1M | $231.2M | ||
| Q3 24 | $65.5M | $228.7M | ||
| Q2 24 | $80.5M | $225.4M | ||
| Q1 24 | $96.2M | $222.9M |
| Q4 25 | $68.9M | $680.9M | ||
| Q3 25 | $54.2M | $667.1M | ||
| Q2 25 | $62.1M | $653.7M | ||
| Q1 25 | $77.7M | $641.8M | ||
| Q4 24 | $110.5M | $633.5M | ||
| Q3 24 | $135.2M | $621.4M | ||
| Q2 24 | $149.9M | $610.4M | ||
| Q1 24 | $167.7M | $602.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | $8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.26× | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | $8.4M | ||
| Q3 25 | $17.4M | $7.8M | ||
| Q2 25 | $-17.7M | $7.6M | ||
| Q1 25 | $-4.0M | $6.0M | ||
| Q4 24 | $-23.4M | $10.2M | ||
| Q3 24 | $12.8M | $7.5M | ||
| Q2 24 | $-18.7M | $6.7M | ||
| Q1 24 | $5.9M | $6.1M |
| Q4 25 | -0.26× | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.34× | ||
| Q1 24 | — | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
